← Back to Search

Other

K-757 + K-833 for Obesity

Phase 2
Waitlist Available
Research Sponsored by Kallyope Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 15 weeks
Awards & highlights

Study Summary

This trial tests a new drug to see if it safely helps people lose weight.

Who is the study for?
This trial is for adults aged 18-70 with obesity (BMI of 30.0 to <40.0) who have been weight stable for the last 3 months and are non-smokers or light smokers. Participants must be willing to follow study procedures, including diet requirements, and use effective contraception during the study. Those with recent weight loss treatments, severe psychiatric disorders, uncontrolled thyroid disease, diabetes mellitus, or using certain medications are excluded.Check my eligibility
What is being tested?
The trial is testing K-757 alone and in combination with K-833 against a placebo to see if they're safe and can help people lose weight effectively. Participants will receive either one of these drugs or a placebo in a controlled environment to compare results.See study design
What are the potential side effects?
While specific side effects aren't listed here, common ones associated with weight loss drugs may include gastrointestinal issues like nausea or constipation, headaches, dizziness, dry mouth, insomnia and potential changes in mood or blood sugar levels.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~15 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 15 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percentage change from baseline in body weight (%) after 13 weeks of treatment
Secondary outcome measures
Change from baseline in body weight (kg) after 13 weeks of treatment
Proportion of participants who discontinued study medication due to an AE
Proportion of participants who experienced 1 or more treatment-emergent AEs
+1 more

Trial Design

3Treatment groups
Experimental Treatment
Group I: Placebo to K-757 and K-833Experimental Treatment1 Intervention
Group II: K-757+K-833Experimental Treatment1 Intervention
Group III: K-757 aloneExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
K-757 and K-833
2023
Completed Phase 2
~240
K-757 and matching placebo to K-833
2023
Completed Phase 2
~150
Matching placebo to K-757 and matching placebo to K-833
2023
Completed Phase 2
~210

Find a Location

Who is running the clinical trial?

Kallyope Inc.Lead Sponsor
3 Previous Clinical Trials
116 Total Patients Enrolled
3 Trials studying Obesity
116 Patients Enrolled for Obesity

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it possible for me to be admitted into this medical experiment?

"To be considered for this medical experimentation, participants must be between 18 and 70 years of age with a diagnosis of obesity. The trial is seeking to enlist approximately 150 individuals."

Answered by AI

Has the Food and Drug Administration sanctioned K-757+K-833 for public consumption?

"Our team at Power assigns K-757+K-833 a score of 2, signifying that while there is evidence to support its safety, the efficacy has yet to be evaluated."

Answered by AI

Are there any open slots for enrolment in this research project?

"The clinical trial is no longer recruiting participants as reported on the database hosted by clinicaltrials.gov. Initially posted in October of 2023 and last updated a month prior, there are 1127 other trials that remain active for enrollment at this juncture."

Answered by AI

Are there numerous healthcare facilities managing this experiment within the state's boundaries?

"The list of clinical research facilities offering this trial is extensive, including Clinical Research Atlanta in Stockbridge, Cotton O'Neil Clinical Research Center in Topeka and L-MARC Research Center in Louisville. A total of 19 sites are participating."

Answered by AI

Are those below the age of seventy considered for this examination?

"This clinical trial is targeting participants between 18 and 70 years of age. Nevertheless, there are separate studies available for those under the legal age (192) and elderly patients (730)."

Answered by AI

Who else is applying?

What site did they apply to?
Summit Headlands LLC
Clinical Trials of Texas, LLC
Washington Center for Weight Management and Research, Inc.
What portion of applicants met pre-screening criteria?
Did not meet criteria
Recent research and studies
clinicaltrials.govStudy
A Study to Evaluate the Safety, Tolerability, and Weight Loss Efficacy of K-757 Alone and in Combination With K-833
2023. "A Study to Evaluate the Safety, Tolerability, and Weight Loss Efficacy of K-757 Alone and in Combination With K-833". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06019559.
All > Vancouver
~95 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top